The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.
about
Type 1 diabetes through the life span: a position statement of the American Diabetes AssociationResponse to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:25Stem cell transplantation improves aging-related diseasesApproach to the obese adolescent with new-onset diabetes.The SEARCH for Diabetes in Youth study: rationale, findings, and future directions.Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptideTreatment effects on measures of body composition in the TODAY clinical trial.Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.Insulin resistance in type 2 diabetic youthObesity and youth diabetes: distinguishing characteristics between islet cell antibody positive vs. negative patients over time.Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY studyProfessional continuous glucose monitoring for the identification of type 1 diabetes mellitus among subjects with insulin therapy.HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.A clinical trial to maintain glycemic control in youth with type 2 diabetes.Rising incidence and challenges of childhood diabetes. A mini review.Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013.Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes.NIH Precision Medicine Initiative: Implications for Diabetes Research.Management of pediatric and adolescent type 2 diabetesCorrelates of treatment patterns among youth with type 2 diabetes.Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetesBone marrow stem cell as a potential treatment for diabetes.Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options.The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes.Utility of diabetes-associated autoantibodies for classification of new onset diabetes in children and adolescents.Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium.Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow--bone marrow transplantation plus concurrent thymic transplantationThe development of next-generation screening and diagnostic platforms will change diabetes care.Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10.HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database.
P2860
Q28242092-82F0C210-516E-43F0-AB96-1BF4BC29D875Q28679307-02613C39-3BB8-4A8E-A925-9C47F436361CQ34391056-2A578695-1F2B-4E0C-9357-6A918DCA6722Q34395471-D4DA499F-9508-48AD-9C89-F24EDA12F591Q34545390-102B0C54-535C-4F64-9638-95306BE358A8Q34571784-89BD0C79-A889-4D02-935F-C63A2C500C45Q34604594-9C8BE759-9CD1-4BD4-BB89-204873D0EF99Q34737186-27975629-9143-4CEA-9994-DE97F5996D5AQ34762316-438C3F04-A056-45B1-8D75-5558E1B4ADADQ34974110-6593FA1D-C44A-4C82-9121-837360BEEED0Q35689171-E1161557-ABA4-4D6D-986F-D1B83D2F343BQ36020592-B2C10AD6-3B8A-466E-B1DE-9BC37F9F5B07Q36151855-1AAE7CC7-D448-4EEF-82BE-71249246E0C3Q36311680-2C40C2CE-07CC-4184-9C86-379855350DD1Q36340078-C53FB656-5A7F-48C5-B40A-26716918A5DBQ36361747-57AD0DBD-8027-47F1-AC51-8F14BF5816B0Q36548007-468535BF-C4CC-47A3-97E9-AFFC64DD0FA4Q36799549-EBC83E38-C800-412E-BB73-AEA7CD2968C2Q37025593-8753049F-78FE-4865-9CDF-87F20575CADDQ37292261-223D9527-58B8-49FB-B6D1-8FD51E095C8EQ37403191-908C4319-8412-4327-B9E9-81671519F977Q37622457-45ED6AB1-F4BA-4F92-BFFD-609EC179DB4AQ38106720-1294C457-D37A-4175-947B-5C9E58D35A7EQ38380568-AB64352F-F588-4D7F-A058-B01E4AAA39B2Q38602464-F2225691-6C21-4865-B423-6294B304CD6BQ40598600-5A22293A-06EF-47B0-8358-1AFC7FBD13B2Q40964404-B5E1353A-970D-4227-AE65-43F38CBB62D9Q41362402-DC03BFDA-81F1-4028-A798-2E4FEFD3BD3CQ42278799-E9568D4A-E813-4BFA-9E93-EC8E22971DE5Q43783553-C33D7FED-8B2B-44B7-860D-9E3A2289DE94Q45414033-1C150B97-4ED7-424B-A670-C935B5B5AAB7
P2860
The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The presence of GAD and IA-2 a ...... results from the TODAY study.
@ast
The presence of GAD and IA-2 a ...... results from the TODAY study.
@en
The presence of GAD and IA-2 a ...... results from the TODAY study.
@nl
type
label
The presence of GAD and IA-2 a ...... results from the TODAY study.
@ast
The presence of GAD and IA-2 a ...... results from the TODAY study.
@en
The presence of GAD and IA-2 a ...... results from the TODAY study.
@nl
prefLabel
The presence of GAD and IA-2 a ...... results from the TODAY study.
@ast
The presence of GAD and IA-2 a ...... results from the TODAY study.
@en
The presence of GAD and IA-2 a ...... results from the TODAY study.
@nl
P2093
P2860
P356
P1433
P1476
The presence of GAD and IA-2 a ...... results from the TODAY study.
@en
P2093
Barbara Linder
Francine Kaufman
Georgeanna J Klingensmith
Kenneth C Copeland
Laura Pyle
Leona Cuttler
Ruth S Weinstock
Santica Marcovina
Sherida E Tollefsen
Silva Arslanian
P2860
P304
P356
10.2337/DC10-0373
P407
P50
P577
2010-06-02T00:00:00Z